LAB short interest
Standard BioTools Inc. · Healthcare · Medical - Specialties · settlement date 2026-09-30
| Shares short | 2,520,686 |
|---|---|
| Change vs prior report | -72,622 (-2.8%) |
| Change over six months | -75.6% |
| Days to cover | 2.72 (sector: 3.78) |
| Average daily volume | 925,491 |
| Rank in Healthcare | #656 of 922 by days to cover |
LAB short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 2,520,686 | -2.8% | 2.72 | 925,491 |
| 2026-09-15 | 2,593,308 | -12.9% | 1.44 | 1,803,273 |
| 2026-08-31 | 2,979,028 | +23.9% | 1.75 | 1,702,005 |
| 2026-08-14 | 2,405,258 | -10.7% | 2.16 | 1,113,541 |
| 2026-07-31 | 2,694,489 | +21.7% | 1.34 | 2,015,651 |
| 2026-07-15 | 2,213,551 | -35.4% | 1.00 | 3,059,750 |
| 2026-06-30 | 3,425,003 | -65.8% | 1.00 | 6,850,088 |
| 2026-06-15 | 10,029,339 | -23.6% | 2.03 | 4,947,644 |
| 2026-05-29 | 13,127,631 | +1.6% | 5.91 | 2,222,425 |
| 2026-05-15 | 12,920,309 | +9.3% | 6.99 | 1,849,667 |
| 2026-04-30 | 11,821,128 | +39.4% | 4.25 | 2,783,179 |
| 2026-04-15 | 8,479,342 | -17.8% | 2.38 | 3,556,516 |
| 2026-03-31 | 10,319,954 | +24.6% | 5.59 | 1,846,849 |
| 2026-03-13 | 8,281,198 | -18.5% | 2.54 | 3,266,118 |
| 2026-02-27 | 10,159,609 | -3.2% | 5.94 | 1,710,284 |
| 2026-02-13 | 10,493,665 | +7.2% | 8.03 | 1,306,199 |
| 2026-01-30 | 9,788,254 | -4.0% | 9.20 | 1,064,308 |
| 2026-01-15 | 10,191,929 | -1.1% | 5.24 | 1,945,334 |
| 2025-12-31 | 10,301,667 | -1.7% | 6.16 | 1,672,914 |
| 2025-12-15 | 10,478,841 | -4.0% | 8.62 | 1,215,818 |
| 2025-11-28 | 10,921,071 | -7.9% | 3.90 | 2,803,089 |
| 2025-11-14 | 11,856,210 | +3.5% | 7.30 | 1,623,116 |
| 2025-10-31 | 11,453,426 | -3.3% | 6.39 | 1,792,419 |
| 2025-10-15 | 11,839,646 | -1.7% | 8.64 | 1,370,677 |
| 2025-09-30 | 12,049,852 | +0.5% | 10.07 | 1,196,398 |
import finzdata as yf
yf.Ticker("LAB").short_interest # every report since 2017
yf.Client().short_interest(["LAB"], start="2018-01-01")Healthcare short interest · LAB price history · Who owns LAB · All short interest